Pharmaids Pharmaceuticals share news and announcements

BSE: 524572Pharmaceuticals & BiotechnologySmall Cap

₹28.92₹0.63 (2.23%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹28.29.

52-week range of traded prices to 23 Oct 2026

₹25.60Low, 1 Jun 2026₹53.90High, 9 Dec 2025

Market cap: ₹102 Cr2,774th largest listed
P/E: Lossover the last 12 months
P/B: 2.1
Dividend yield: Nonein the last 12 months
ROE: −8.5%
ROE without one-offs: −21.1%
ROCE: −15.8%
Debt to equity: 0.44
Volume, BSE: 1,482

Pharmaids Pharmaceuticals board meetings

125 filed, newest first. Page 1 of 3.

Aug 2026
- 6 Aug · Board meeting
  Meeting on 12 Aug 2026: quarterly results
- 6 Aug · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve the Unaudited Financial .... (opens in a new tab)
May 2026
- 22 May · Board meeting
  Meeting on 29 May 2026: audited results
- 22 May · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve the Audited Financial .... (opens in a new tab)
Feb 2026
- 9 Feb · Board meeting
  Meeting on 12 Feb 2026: quarterly results
- 9 Feb · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve the Unaudited Financial .... (opens in a new tab)
Nov 2025
- 6 Nov · Board meeting
  Meeting on 11 Nov 2025: quarterly results
- 6 Nov · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 11/11/2025 ,inter alia, to consider and approve the Unaudited Financial .... (opens in a new tab)
Aug 2025
- 21 Aug · Board meeting
  Outcome of the Board Meeting held on August 21, 2025. (opens in a new tab)
- 4 Aug · Board meeting
  Meeting on 7 Aug 2025: quarterly results
- 4 Aug · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 07/08/2025 ,inter alia, to consider and approve the Unaudited Financial .... (opens in a new tab)
Jul 2025
- 4 Jul · Board meeting
  Outcome of the Board Meeting held on Friday, July 07, 2025. (opens in a new tab)
May 2025
- 23 May · Board meeting
  Board of Directors of the Company have approved the Audited Financial Results for the Quarter and Year ended March 31st 2025 at their meeting held on May 23, 2025. (opens in a new tab)
- 20 May · Board meeting
  Meeting on 23 May 2025: audited results
- 20 May · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 23/05/2025 ,inter alia, to consider and approve the Audited Financial .... (opens in a new tab)
Feb 2025
- 7 Feb · Board meeting
  Meeting on 12 Feb 2025: quarterly results
- 7 Feb · Board meeting
  PHARMAIDS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 ,inter alia, to consider and approve the unaudited Financial .... (opens in a new tab)
Nov 2024
- 7 Nov · Board meeting
  Meeting on 13 Nov 2024: quarterly results
- 7 Nov · Board meeting
  PHARMAIDS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 ,inter alia, to consider and approve the unaudited financial .... (opens in a new tab)
Aug 2024
- 28 Aug · Board meeting
  Outcome of the Board Meeting held on 28th August 2024, for approval of Annual Financial Statements for the financial year 2023-24 and AGM related matters. (opens in a new tab)
- 20 Aug · Board meeting
  Meeting on 28 Aug 2024: annual general meeting
- 20 Aug · Board meeting
  PHARMAIDS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/08/2024 ,inter alia, to consider and approve the Audited Financial .... (opens in a new tab)
- 13 Aug · Board meeting
  Financial Results for the quarter ended 30th June 2024 (opens in a new tab)
- 5 Aug · Board meeting
  PHARMAIDS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 ,inter alia, to consider and approve the Unaudited Financial .... (opens in a new tab)
May 2024
- 28 May · Board meeting
  Board of Directors of the Company have approved the Audited Financial Results for the Quarter and Year ended March 31st 2024 at their meeting held on May 28, 2024. (opens in a new tab)
- 21 May · Board meeting
  Meeting on 28 May 2024: audited results
- 20 May · Board meeting
  PHARMAIDS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2024 ,inter alia, to consider and approve the Audited Financial .... (opens in a new tab)
Mar 2024
- 2 Mar · Board meeting
  We hereby inform that Board of Directors of the Company at its meeting held today i.e; March 02, 2024, approved the allotment of 1,28,56,578 fully paid up Equity Shares for the Consideration .... (opens in a new tab)
Feb 2024
- 12 Feb · Board meeting
  Board at its meeting held on 12th February 2024, have considered declaration of financial results for the quarter and nine months ended 31st December 2023 amongst other important matters. (opens in a new tab)
- 2 Feb · Board meeting
  Meeting on 12 Feb 2024: quarterly results
- 2 Feb · Board meeting
  PHARMAIDS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 ,inter alia, to consider and approve the unaudited financial .... (opens in a new tab)
Jan 2024
- 6 Jan · Board meeting
  Outcome of the Board meeting held on saturday, 06 January 2024. (opens in a new tab)
- 3 Jan · Board meeting
  Meeting on 6 Jan 2024: employees stock option plan, increase in authorised capital and preferential issue of shares
- 3 Jan · Board meeting
  PHARMAIDS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/01/2024 ,inter alia, to consider and approve Pursuant to Regulation .... (opens in a new tab)
Nov 2023
- 11 Nov · Board meeting
  Outcome of the Board Meeting held on 11th September , 2023 for approval of unaudited Standalone and Consolidated financial results for the quarter and half year ended 30th September 2023. (opens in a new tab)
- 6 Nov · Board meeting
  Meeting on 11 Nov 2023: quarterly results
- 4 Nov · Board meeting
  PHARMAIDS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2023 ,inter alia, to consider and approve Unaudited Financial .... (opens in a new tab)
Aug 2023
- 29 Aug · Board meeting
  Outcome of the Board Meeting held on 29th August , 2023 for approval of Annual Financial Statements for the financial year 2022-23 and AGM related matters. (opens in a new tab)
- 23 Aug · Board meeting
  Meeting on 29 Aug 2023
- 22 Aug · Board meeting
  PHARMAIDS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/08/2023 ,inter alia, to consider and approve the Audited Financial .... (opens in a new tab)
Jul 2023
- 28 Jul · Board meeting
  Meeting on 4 Aug 2023: quarterly results
- 28 Jul · Board meeting
  PHARMAIDS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2023 ,inter alia, to consider and approve Unaudited Financial .... (opens in a new tab)
May 2023
- 23 May · Board meeting
  Meeting on 29 May 2023: audited results
- 23 May · Board meeting
  PHARMAIDS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 ,inter alia, to consider and approve Audited Financial .... (opens in a new tab)
Feb 2023
- 13 Feb · Board meeting
  Board of Directors of the Company have approved Unaudited Financial results for the quarter and nine months ended 31st December 2022 and taking land on sub-lease in its meeting held .... (opens in a new tab)
- 3 Feb · Board meeting
  Meeting on 13 Feb 2023: quarterly results
- 3 Feb · Board meeting
  PHARMAIDS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 ,inter alia, to consider and approve the un-audited financial .... (opens in a new tab)
Jan 2023
- 17 Jan · Board meeting
  Revised outcome for the Board meeting held on 17th January, 2023 (opens in a new tab)
- 17 Jan · Board meeting
  Dear Sir/Madam, Outcome of the Board Meeting held on 06.12.2022 for Conversion of Share Warrants and allotment of Equity shares pursuant to the Conversion, Convening of the EGM and other .... (opens in a new tab)
- 12 Jan · Board meeting
  Meeting on 17 Jan 2023

Pharmaids Pharmaceuticals board meetings

Aug 2026

May 2026

Feb 2026

Nov 2025

Aug 2025

Jul 2025

May 2025

Feb 2025

Nov 2024

Aug 2024

May 2024

Mar 2024

Feb 2024

Jan 2024

Nov 2023

Aug 2023

Jul 2023

May 2023

Feb 2023

Jan 2023